Direct from our Health Canada site-licensed, GMP-certified contract manufacturing facilities. Bulk supply, customized OEM white-label solutions, and verified active marker assays.
The global market for botanical extracts, herbal dietary supplements, and specialized nutraceutical formulations is undergoing a profound structural evolution. Modern brand owners, pharmaceutical-grade importers, and retail chains no longer evaluate custom OEM wholesale herbs factories & factory partners solely on unit price per bottle or raw material cost per kilogram. Today, competitive advantage is dictated by rigorous analytical assay verification, full supply chain transparency, international regulatory compliance (such as Health Canada NPN licensing, US FDA cGMP compliance, and EU Novel Food frameworks), and advanced galenic delivery technologies.
As a premiere contract manufacturer headquartered in Ontario, Canada, with over 25 years of specialized experience, NutraLab Canada Corp. operates at the nexus of traditional botanical wisdom and modern pharmaceutical-grade biotechnology. Operating out of a state-of-the-art Health Canada site-licensed facility, we empower brand innovators across 35+ international markets with end-to-end custom formulation, high-potency bio-extraction, dosage engineering, and fully integrated in-house primary and secondary packaging.
Strategic purchasing managers and OEM procurement directors must align their supply chain architectures with emerging consumer demands and escalating regulatory standards. Key industry trajectories defining the custom OEM wholesale herbs landscape include:
Generic dry plant powders are rapidly being replaced by standardized extracts quantified via High-Performance Liquid Chromatography (HPLC) and Ultra-Performance Liquid Chromatography (UPLC). Buyers now demand guaranteed levels of bioactive markers—such as 50% Phosphatidic Acid, total Fulvic Acid complexes in Shilajit, or concentrated Ursodeoxycholic Acid derivatives like TUDCA.
Consumer aversion to chemical residues (such as hexane, acetone, or methanol) has accelerated the adoption of Supercritical Carbon Dioxide ($CO_2$) extraction and enzymatic hydrolysis. These methods preserve thermolabile phyto-nutrients, eliminate toxic solvent carryover, and provide superior organoleptic profiles.
Modern botanical products increasingly combine standardized botanical actives with specialized amino acids (such as DL-Methionine), bio-enhanced peptides (such as Hydrolyzed Marine Collagen), and energy substrates (Creatine Monohydrate) to create multi-target functional health products with proven physiological benefits.
A true OEM manufacturing partner must offer full structural versatility across multiple galenic dosage formats. Operating from single-source automated production halls, NutraLab handles six core dosage forms, eliminating multi-vendor handoffs and preventing cross-contamination risks:
When selecting a supplier among custom OEM wholesale herbs factories, international buyers must mitigate regulatory, quality, and supply-chain liabilities. NutraLab Canada Corp. provides a verifiable track record of regulatory mastery, robust quality management systems, and comprehensive post-market support.
Our facility at 980 Tapscott Rd, Scarborough, Ontario, holds an official Health Canada Site Licence. Every batch is manufactured under strict cGMP protocols, guaranteeing full batch records, analytical traceability, and audit-ready documentation.
We take the friction out of cross-border customs clearance. Our dedicated regulatory staff handles Natural Product Number (NPN) registration, Certificate of Analysis (CoA) issuance, and Certificate of Free Sale (CFS) documentation for over 35 global destinations.
Bulk product never leaves our controlled cleanroom environment prior to finishing. We offer complete in-house bottling, induction sealing, blister packaging, liquid/powder sachets, combination tablet packs, and automated cartoning.
Below are essential technical and operational queries routinely evaluated by B2B buyers, procurement specialists, and brand strategists when establishing contract manufacturing agreements.
MOQs depend directly on the chosen dosage form and packaging specifications. Encapsulated powders, compressed tablets, and dry powder blends generally offer lower initial MOQs (starting around 50,000 to 100,000 units), whereas complex galenic forms like softgels or custom gummies require larger minimum batch runs to ensure volumetric uniformity, accurate fill weight, and consistent active dispersion across the production line. Detailed pricing tiers and exact minimum batch sizes are provided in every custom quotation.
Every incoming lot of raw herbal material undergoes a mandatory Quality Control quarantine protocol. We utilize High-Performance Liquid Chromatography (HPLC) for active marker quantification, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal screening (lead, arsenic, cadmium, mercury), thin-layer chromatography (TLC) for botanical species identity validation, and automated microbiology screening for pathogens, yeast, and molds. A finished product Certificate of Analysis (CoA) is issued only after all release criteria are fully met.
A standard new OEM project moves through six distinct phases: 1) Initial Technical Consultation & Formulation Brief, 2) R&D Formulation & Raw Material Sourcing, 3) Regulatory Compliance Review & NPN Application (if applicable), 4) Label Artwork Approval & Packaging Proofing, 5) GMP Manufacturing & Quality Release Testing, and 6) Finishing, Packaging, and Global Logistics. Existing stock formulas can move into production rapidly, whereas fully custom proprietary formulas requiring Health Canada licensing approvals may take longer depending on government review timelines.
Yes. Our dedicated in-house regulatory affairs department routinely prepares comprehensive export documentation packages. This includes Health Canada Natural Product Numbers (NPN), Certificates of Free Sale (CFS), Certificates of Analysis (CoA), BSE/TSE-Free Statements, Halal and Kosher compliance documentation, and detailed ingredient origin declarations required by customs authorities across North America, Europe, Asia, and the Middle East.
Absolutely. Intellectual Property protection is a cornerstone of our commercial partnerships. We routinely execute bilateral Non-Disclosure and Confidentiality Agreements prior to receiving proprietary customer formulas, target specs, or brand design assets. Your custom formulas remain 100% your brand's intellectual property.
Partner with a Health Canada site-licensed, cGMP contract manufacturer with 25 years of proven international expertise. Contact our technical sales team today for custom formulation assistance, batch quotations, and sample requests.
Get a Quote